Mangoceuticals MGRX Cash Flow Statement (2023-2026)

NASDAQ MGRX
$0.44 +0.06 (+15.51%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Mangoceuticals Quarterly Cash Flow Statement

Periods 14 quarters
Latest Jun 2026

Mangoceuticals reported cash from operations of -$0.26M and free cash flow of -$0.26M for the quarter ended Jun 2026, up 79.3% year over year. This cash flow statement covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M-2.77M-3.40M-1.31M
Depreciation and DepletionDep. & Depletion 0.01M0.01M0.01M0.01M0.01M0.00M252.00255.00250.00252.00255.00255.00250.00252.00
Share-based CompensationStock Comp. 0.70M0.39M0.08M0.36M0.42M0.81M0.46M0.42M1.94M3.18M5.54M0.06M1.09M0.01M
Cash from OperationsCash from Ops. -1.81M-1.78M-1.71M-1.70M-0.99M-1.58M-1.17M-1.13M-2.27M-1.26M-1.24M-1.08M-1.31M-0.26M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles 0.28M0.28M0.28M0.28M
Depreciation & Amortization (CF)Dep. & Amort. 0.01M0.01M0.01M0.01M0.01M0.00M255.00250.00252.00256.00255.00250.00252.00
Change in Working Capital
Change in InventoryChange Inventory -0.00M-0.00M-0.00M-433.00-806.00
Change in Account PayablesChange Payables -0.11M
Change in Accured ExpensesChange Accured Exp. -0.00M0.10M-0.04M0.05M0.91M-0.33M-0.01M0.13M0.34M0.09M-0.28M-0.10M0.11M0.36M
Change in TaxesChange Taxes 0.00M-0.00M0.00M-0.00M893.00-0.01M0.00M0.00M-0.01M0.00M
Other Working Capital ChangesOther WC Changes 0.02M0.02M0.03M-0.13M-0.02M-0.03M-0.01M0.05M-0.02M-0.02M0.13M-0.17M-0.01M0.29M
Investing Activities
Capital ExpendituresCapex 0.00M
Cash from Investing ActivitiesCash from Investing -0.00M
Financing Activities
Cash from Financing ActivitiesCash from Financing 5.00M0.86M1.20M0.27M1.99M0.75M1.12M2.29M1.28M1.62M2.08M
Debt Issuance and Repayment
Non-Current Debt -0.08M0.09M-0.04M
Current Debt -0.04M0.07M
Change in Capital Stock
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued 0.75M0.40M1.15M-1.05M
Net Equity Issued and RepurchasedNet Equity Issued 5.00M1.20M0.18M0.39M0.76M0.66M0.43M1.32M2.21M
Additional items
Exchange Rate EffectFX Effect -70.00-0.00M-497.00-0.01M0.01M187.00-45.00-681.00-433.00-0.00M
Change in Cash 3.19M-0.92M-1.71M-0.50M-0.72M0.48M-0.42M-0.01M0.01M0.02M0.38M1.01M-1.31M0.06M
Free Cash FlowFCF -1.81M-1.78M-1.71M-1.70M-0.99M-1.58M-1.17M-1.13M-2.27M-1.26M-1.24M-1.08M-1.31M-0.26M
Net Cash FlowNCF 3.19M-0.92M-1.71M-0.50M-0.72M0.41M-0.42M-0.01M0.01M0.02M0.38M1.01M-1.31M-0.26M

Mangoceuticals Cash Flow Statement API

Pull Mangoceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MGRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY